US5683436A - Treatment of rhinitis by biostimulative illumination - Google Patents

Treatment of rhinitis by biostimulative illumination Download PDF

Info

Publication number
US5683436A
US5683436A US08/292,717 US29271794A US5683436A US 5683436 A US5683436 A US 5683436A US 29271794 A US29271794 A US 29271794A US 5683436 A US5683436 A US 5683436A
Authority
US
United States
Prior art keywords
rhinitis
light emitting
accordance
treatment
nostril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/292,717
Inventor
Emanuel Mendes
Ittai Neuman
Original Assignee
Amron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amron Ltd filed Critical Amron Ltd
Assigned to AMRON, LTD. reassignment AMRON, LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MENDES, EMANUEL, NEUMAN, ITAII
Application granted granted Critical
Publication of US5683436A publication Critical patent/US5683436A/en
Assigned to SYRO LTD. reassignment SYRO LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMRON, LTD.
Assigned to SYRO TECHNOLOGIES, INC. reassignment SYRO TECHNOLOGIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SYRO LTD.
Assigned to SYRO RESEARCH & DEVELOPMENT TECHNOLOGIES LTD. reassignment SYRO RESEARCH & DEVELOPMENT TECHNOLOGIES LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SYRO TECHNOLOGIES, INC.
Assigned to MENDES, EMANUEL reassignment MENDES, EMANUEL ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SYRO RESEARCH & DEVELOPMENT TECHNOLOGIES LTD.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • A61N5/0603Apparatus for use inside the body for treatment of body cavities
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • A61N5/0603Apparatus for use inside the body for treatment of body cavities
    • A61N2005/0605Ear
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • A61N5/0603Apparatus for use inside the body for treatment of body cavities
    • A61N2005/0607Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0635Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0644Handheld applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/065Light sources therefor
    • A61N2005/0651Diodes
    • A61N2005/0652Arrays of diodes

Definitions

  • the present invention relates to light therapy in general and, more particularly, to devices and methods for treating the rhinitis.
  • rhinitis such as a runny nose, an itchy nose, post nasal drainage of mucus and, in extreme cases, congested secondary air passages
  • the common etiologies are viral infection, such as infectious rhino sinusitis.
  • Other etiologies include allergic, perennial, or seasonal rhinitis, also known as "hay fever", non allergic vasomotor rhinitis, eosinophyllic rhinitis and nasal polyps.
  • Light therapy is known for treating a variety of patient complaints and ailments.
  • a state of the art device suitable for administering light therapy is disclosed in U.S. Pat. No. 4,930,504 to Diamantopoulos et al.
  • Diamantopoulos et al hypothesize that the disclosed device may be used, "for example, to treat inflammations, wounds, burns, chronic ulcerations including diabetic ulcers, deficient circulation, pain, nerve degeneration, eczema, shingles, infection, scars, acne, bone fractures, muscle and ligament injuries, arthritis, osteo-arthritis, rheumatiodal arthritis, skin grafts, gingival irritation, oral ulcers, dental pain and swelling, cellulitis, stretch marks, skin tone, alopecia areata, trigeminal neuralgia, herpes, zosten, sciatica, cervical erosions and other conditions.”
  • Diamantopoulos et al teach the use of an array of substantially monochromatic radiation sources of a plurality of wavelengths, preferably of at least three different wavelengths.
  • the sources radiate in accordance with a high duty-cycle pulsed rate, and are arranged within the array such that radiation of at least two different wavelengths passes directly or indirectly through a single point located within the treated tissue.
  • the present invention seeks to provide a method and apparatus for therapeutic illumination which are particularly suited for treatment of rhinitis.
  • the apparatus and method of the present invention is suitable for treatment of various nasal conditions.
  • a method of treating rhinitis by illumination including the steps of:
  • a rhinitis affected zone of the interior of a nostril with non-coherent light radiation emitted by at least one light emitting diode (LED), the light radiation having a narrow bandwidth centered at a wavelength suitable for rhinitis treatment;
  • LED light emitting diode
  • the non-coherent light radiation is continuous wave (CW) light radiation.
  • the narrow bandwidth comprises a red light bandwidth.
  • the red light wavelength is approximately 660 nm.
  • the at least one LEDs comprises a plurality of LEDs arranged in a LED pack adapted for insertion into the rhinitis affected nostril.
  • the LED pack comprises at least one concentric circular arrangement of LEDs.
  • each of the plurality of LEDs emits a cone of light
  • the method described above further includes the step of configuring and arranging the LEDs such that the plurality of cones of light emitted by the plurality of LEDs illuminate a common area of said zone.
  • the rhinitis affected zone is illuminated at a power concentration level of between approximately one milliwatt per squared centimeter and approximately thirty milliwatts per squared centimeter. More preferably, the rhinitis affected zone is illuminated at a power concentration level of between approximately one milliwatt per squared centimeter and approximately thirty milliwatts per squared centimeter.
  • apparatus for treating rhinitis by illumination including at least one light emitting diode (LED) pack, each having a plurality of light emitting diodes (LEDs), suitable for insertion into at least one, respective, rhinitis affected nostril and operative for illuminating a rhinitis affected zone of the interior surface of the at least one nostril with non-coherent light radiation, the light radiation having a narrow bandwidth centered at a wavelength suitable for rhinitis treatment.
  • LED light emitting diode
  • LEDs light emitting diodes
  • the non-coherent light radiation is continuous wave (CW) light radiation.
  • the narrow bandwidth comprises a red light bandwidth. More preferably, the red light wavelength is approximately 660 nm.
  • the LED pack comprises at least one concentric circular arrangement of LEDs.
  • each of the LEDs emits a cone of light and the LEDs are arranged and configured such that the plurality of cones of light illuminate a common area of said zone.
  • the rhinitis affected zone is illuminated at a power concentration level of between approximately one milliwatt per squared centimeter and approximately thirty milliwatts per squared centimeter.
  • the apparatus for treating rhinitis further includes a support arrangement, adapted for mounting on the face of a user and operative for supporting the at least one LED pack at a position suitable for biostimulative treatment of the at least one rhinitis affected nostril.
  • FIG. 1 is a simplified block diagram functionally showing apparatus for treating rhinitis, constructed and operative in accordance with a preferred embodiment of the present invention
  • FIG. 2 shows the LEDs of FIG. 1 in greater detail
  • FIG. 3 is a schematic, pictorial, illustration of apparatus for treating rhinitis, constructed and operative in accordance with one preferred embodiment of the present invention
  • FIG. 4 is a schematic, pictorial, illustration of apparatus for treating rhinitis, constructed and operative in accordance with another preferred embodiment of the present invention.
  • FIG. 5 is a schematic, pictorial, illustration of apparatus for treating rhinitis, constructed and operative in accordance with yet another preferred embodiment of the present invention.
  • Light source 1 preferably comprises a plurality of light emitting diodes (LEDs) 4 which receive power via a driver circuit 6.
  • LEDs 4 Preferably, each of LEDs 4 emits light of substantially the same frequency.
  • Control unit 2 includes a power supply 7 and a timer 10 which may include a standard clock circuit provided with "set time” switches, and whose function is to disable the control circuit 2 after a preset time has elapsed.
  • Power supply 7 preferably includes a battery, such as a lithium battery, or an AC/DC converter which draws electric power from the grid.
  • An amplitude and/or duty cycle variation circuit 12 provides a direct current (DC) signal with a variable amplitude and/or duty cycle which is fed to driver 6 of light source 1.
  • DC direct current
  • light source 1 emits light continuously with a magnitude and/or duty cycle determined by amplitude/duty cycle variation circuit 12.
  • LEDs 4 are driven by driver 6 in the CW mode of operation controlled by control unit 2.
  • Experimental results show that a pure CW mode of operation is more effective than either a PW (pulsed wave) mode of operation or any combination of the two modes.
  • FIG. 2 shows a preferred embodiment of LEDs 4 in detail.
  • the LEDs 4 are arranged in the form of an LED pack 20 including a preselected number of LEDs.
  • LED pack 20 includes three LEDs, 22, 23 and 24, connected in series.
  • LEDs 22, 23 and 24 are preferably connected, in series with a resistor 26 which limits the current flowing through the LEDs, between a high voltage DC rail 28 and a low voltage DC rail 30.
  • one terminal of series resistor 26 is connected to high voltage rail 28 whilst the cathode of LED 24 is connected to low voltage rail 30.
  • series resistor 26 and power supply 7 may be replaced by a current source.
  • FIG. 3 shows a preferred arrangement of LED pack 20 which is shown schematically in FIG. 2.
  • LEDs 4 are preferably mounted on a support base 40 and arranged such that their light outputs illuminate a defined zone 42, for example a rhinitis-afflicted region of the internal surface 45 of a human nostril 50.
  • zone 42 which LEDs 4 illuminate is adapted to cover most of the internal surface of a typical human nostril with substantially homogeneous illumination intensity.
  • the LEDs may be arranged in any suitable manner on base 40, for example in one or more concentric circles. It will be understood that, generally, the number of LEDs included in LED pack 20 of FIG. 2 controls the light output intensity of light source 1 (FIG. 1).
  • each of LEDs 4 emits a cone of light
  • the LEDs are configured and arranged such that the plurality of cones of light emitted by the plurality of LEDs intersects over zone 42, such that more than one of LEDs 4 illuminate a common area of zone 42.
  • every point of zone 42 is illuminated by more than one of LEDs 4.
  • amplitude and/or duty cycle variation circuit 12 provides a DC voltage with variable amplitude and/or duty cycle between high voltage supply rail 28 and ground terminal 30.
  • variation circuit 12 is set to a substantially continuous-wave mode of operation.
  • a preferred power level is between 1-30 mW/cm 2 , for example 10 mW/cm 2 .
  • the invention affords low cost apparatus for treating rhinitis by producing a non-coherent source of illumination, preferably in CW mode, which is focussed over a predefined area.
  • the exact wavelength of the illumination is confined to a relatively narrow bandwidth ( ⁇ 25 nm) centered at a wavelength which may be predetermined and provided by suitable selection of LEDs 4 in LED pack 20.
  • red light particularly 660 nm light, is particularly suitable for the treatment of rhinitis.
  • the average intensity of the emitted illumination may be varied by the operator, and the therapy duration may be preset by means of the integral timer circuit 10.
  • FIG. 4 schematically illustrates an alternative, preferred, embodiment of the invention which may be particularly useful for patients requiring repeated treatment over prolonged periods of time.
  • at least one light source 1 is securely, yet adjustably, mounted on a generally rigid support arrangement 70 which is mounted, in turn, on the face of a user.
  • Support arrangement 70 preferably includes two ear supports 72 and a nose-top support 74, such as the ear and nose supports of eye glasses, so as to provide secure mounting of arrangement 70 on the face of the user.
  • Each of the at least one light sources 1 is preferably mounted on an adjustable downward extension 76 of arrangement 70.
  • FIG. 4 shows two light sources 1 mounted on two, respective, extensions 76 of arrangement 70, which are adjusted such that light sources 1 operatively engage the two nostrils of the user, respectively.
  • Light sources 1 are preferably powered and controlled, via suitable wires 75, by a control unit 78, similar to control unit 2 (FIGS. 1-3) but adapted to power and control more than one light source 1.
  • Control unit 78 may be hand held or mounted to any suitable location on the user or placed at any other suitable location. Using this preferred embodiment of the invention, biostimulative illumination treatment as described above may be conveniently applied to both nostrils simultaneously.
  • FIG. 5 schematically illustrates another alternative, preferred, embodiment of the invention, wherein light source 1 and control unit 2 (FIGS. 1-3) are integrated into a single light treatment device 80.
  • Treatment device 80 preferably includes an elongated, preferably pen-shaped, housing 82 which encloses circuitry substantially equivalent to that of control unit 2 and light source 1.
  • a LED pack 84 which may be identical to LED pack 20 (FIG. 3), is disposed at one end of housing 82 and connected to the circuitry in housing 82 in the manner described above with reference to FIG. 2.
  • treatment device 80 may be hand held by the user, preferably at a prescribed position suitable for biostimulative illumination treatment.
  • LED pack 84 operatively engages a rhinitis affected nostril for biostimulative treatment thereof, as described above with reference to FIGS. 1-3.
  • Device 80 is preferably powered by a compact power source, such as a lithium battery.
  • LED pack 20 of light source 1 is preferably inserted to one of nostrils 50 of a rhinitis-suffering human nose 60 and, then, activated for a preselected treatment duration, for example three minutes. Then, light source 1 is removed from the treated nostril 50 and inserted to the other, untreated, nostril 50 for substantially the same treatment. This completes one rhinitis treatment session. For best results, the session described above is performed repeatedly, a number of times each day, over long periods of time, typically a few months.

Abstract

Apparatus for treating rhinitis by illumination including at least one light emitting diode (LED) pack, each having a plurality of light emitting diodes (LEDs), suitable for insertion into at least one, respective, rhinitis affected nostril and operative for illuminating a rhinitis affected zone of the interior surface of the at least one nostril with non-coherent light radiation, the light radiation having a narrow bandwidth centered at a wavelength suitable for rhinitis treatment. Preferably, the rhinitis affected zone is illuminated continuously for a prescribed treatment duration.

Description

FIELD OF THE INVENTION
The present invention relates to light therapy in general and, more particularly, to devices and methods for treating the rhinitis.
BACKGROUND OF THE INVENTION
Clinical symptoms of rhinitis such as a runny nose, an itchy nose, post nasal drainage of mucus and, in extreme cases, congested secondary air passages, may be attributed to various etiologies. The common etiologies are viral infection, such as infectious rhino sinusitis. Other etiologies include allergic, perennial, or seasonal rhinitis, also known as "hay fever", non allergic vasomotor rhinitis, eosinophyllic rhinitis and nasal polyps.
Existing methods of treatment of the above mentioned rhinitis symptoms include systematic use of medications, such as antihistamines and decongestants, or local treatment with steroid spray, D.S.C.G. or local decongestants. There have been also attempts to treat rhinitis locally by applying a "fog stream", i.e. a stream of water at a temperature of approximately 42° C.
It is appreciated that none of the existing treatments described above, nor any combinations thereof, completely relieve rhinitis related symptoms. Therefore, a large population is helplessly exposed to the irritating discomforts of rhinitis symptoms.
Light therapy is known for treating a variety of patient complaints and ailments. A state of the art device suitable for administering light therapy is disclosed in U.S. Pat. No. 4,930,504 to Diamantopoulos et al. Diamantopoulos et al hypothesize that the disclosed device may be used, "for example, to treat inflammations, wounds, burns, chronic ulcerations including diabetic ulcers, deficient circulation, pain, nerve degeneration, eczema, shingles, infection, scars, acne, bone fractures, muscle and ligament injuries, arthritis, osteo-arthritis, rheumatiodal arthritis, skin grafts, gingival irritation, oral ulcers, dental pain and swelling, cellulitis, stretch marks, skin tone, alopecia areata, trigeminal neuralgia, herpes, zosten, sciatica, cervical erosions and other conditions."
Diamantopoulos et al teach the use of an array of substantially monochromatic radiation sources of a plurality of wavelengths, preferably of at least three different wavelengths. The sources radiate in accordance with a high duty-cycle pulsed rate, and are arranged within the array such that radiation of at least two different wavelengths passes directly or indirectly through a single point located within the treated tissue.
Use of LEDs in administering light therapy for the treatment of certain ailments and complaints is disclosed in Applicant's published UK Application GB 2212010A.
SUMMARY OF THE INVENTION
The present invention seeks to provide a method and apparatus for therapeutic illumination which are particularly suited for treatment of rhinitis. The apparatus and method of the present invention is suitable for treatment of various nasal conditions.
There is thus provided, in accordance with a preferred embodiment of the present invention, a method of treating rhinitis by illumination including the steps of:
illuminating a rhinitis affected zone of the interior of a nostril with non-coherent light radiation emitted by at least one light emitting diode (LED), the light radiation having a narrow bandwidth centered at a wavelength suitable for rhinitis treatment;
maintaining the light radiation for a prescribed treatment duration.
In a preferred embodiment of the invention, the non-coherent light radiation is continuous wave (CW) light radiation.
In a preferred embodiment of the invention, the narrow bandwidth comprises a red light bandwidth. Preferably, the red light wavelength is approximately 660 nm.
Further, in accordance with a preferred embodiment of the invention, the at least one LEDs comprises a plurality of LEDs arranged in a LED pack adapted for insertion into the rhinitis affected nostril. Preferably, the LED pack comprises at least one concentric circular arrangement of LEDs.
Additionally, in a preferred embodiment of the present invention, each of the plurality of LEDs emits a cone of light, and the method described above further includes the step of configuring and arranging the LEDs such that the plurality of cones of light emitted by the plurality of LEDs illuminate a common area of said zone.
Preferably, the rhinitis affected zone is illuminated at a power concentration level of between approximately one milliwatt per squared centimeter and approximately thirty milliwatts per squared centimeter. More preferably, the rhinitis affected zone is illuminated at a power concentration level of between approximately one milliwatt per squared centimeter and approximately thirty milliwatts per squared centimeter.
Further, in accordance with a preferred embodiment of the invention, there is provided apparatus for treating rhinitis by illumination including at least one light emitting diode (LED) pack, each having a plurality of light emitting diodes (LEDs), suitable for insertion into at least one, respective, rhinitis affected nostril and operative for illuminating a rhinitis affected zone of the interior surface of the at least one nostril with non-coherent light radiation, the light radiation having a narrow bandwidth centered at a wavelength suitable for rhinitis treatment.
In a preferred embodiment, the non-coherent light radiation is continuous wave (CW) light radiation.
Preferably, the narrow bandwidth comprises a red light bandwidth. More preferably, the red light wavelength is approximately 660 nm.
In a preferred embodiment of the invention, the LED pack comprises at least one concentric circular arrangement of LEDs. Preferably, each of the LEDs emits a cone of light and the LEDs are arranged and configured such that the plurality of cones of light illuminate a common area of said zone.
Preferably, the rhinitis affected zone is illuminated at a power concentration level of between approximately one milliwatt per squared centimeter and approximately thirty milliwatts per squared centimeter.
According to one, preferred, embodiment of the invention the apparatus for treating rhinitis further includes a support arrangement, adapted for mounting on the face of a user and operative for supporting the at least one LED pack at a position suitable for biostimulative treatment of the at least one rhinitis affected nostril.
BRIEF DESCRIPTION OF THE DRAWINGS
The present invention will be understood and appreciated more fully from the following detailed description, taken in conjunction with the following drawings in which:
FIG. 1 is a simplified block diagram functionally showing apparatus for treating rhinitis, constructed and operative in accordance with a preferred embodiment of the present invention;
FIG. 2 shows the LEDs of FIG. 1 in greater detail;
FIG. 3 is a schematic, pictorial, illustration of apparatus for treating rhinitis, constructed and operative in accordance with one preferred embodiment of the present invention;
FIG. 4 is a schematic, pictorial, illustration of apparatus for treating rhinitis, constructed and operative in accordance with another preferred embodiment of the present invention; and
FIG. 5 is a schematic, pictorial, illustration of apparatus for treating rhinitis, constructed and operative in accordance with yet another preferred embodiment of the present invention.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
Referring to FIG. 1, there is shown a compact light source 1 and an associated control unit 2 which preferably has a CW (continuous wave) mode of operation. Light source 1 preferably comprises a plurality of light emitting diodes (LEDs) 4 which receive power via a driver circuit 6. Preferably, each of LEDs 4 emits light of substantially the same frequency.
Control unit 2 includes a power supply 7 and a timer 10 which may include a standard clock circuit provided with "set time" switches, and whose function is to disable the control circuit 2 after a preset time has elapsed. Power supply 7 preferably includes a battery, such as a lithium battery, or an AC/DC converter which draws electric power from the grid.
An amplitude and/or duty cycle variation circuit 12 provides a direct current (DC) signal with a variable amplitude and/or duty cycle which is fed to driver 6 of light source 1. Thus, light source 1 emits light continuously with a magnitude and/or duty cycle determined by amplitude/duty cycle variation circuit 12.
In a preferred embodiment of the invention, LEDs 4 are driven by driver 6 in the CW mode of operation controlled by control unit 2. Experimental results show that a pure CW mode of operation is more effective than either a PW (pulsed wave) mode of operation or any combination of the two modes.
FIG. 2 shows a preferred embodiment of LEDs 4 in detail. The LEDs 4 are arranged in the form of an LED pack 20 including a preselected number of LEDs. In the example shown in FIG. 2, LED pack 20 includes three LEDs, 22, 23 and 24, connected in series. LEDs 22, 23 and 24 are preferably connected, in series with a resistor 26 which limits the current flowing through the LEDs, between a high voltage DC rail 28 and a low voltage DC rail 30. In the example of FIG. 2, one terminal of series resistor 26 is connected to high voltage rail 28 whilst the cathode of LED 24 is connected to low voltage rail 30.
According to an alternative embodiment of the invention, series resistor 26 and power supply 7 may be replaced by a current source.
FIG. 3 shows a preferred arrangement of LED pack 20 which is shown schematically in FIG. 2. LEDs 4 are preferably mounted on a support base 40 and arranged such that their light outputs illuminate a defined zone 42, for example a rhinitis-afflicted region of the internal surface 45 of a human nostril 50. In a preferred embodiment of the invention, zone 42 which LEDs 4 illuminate is adapted to cover most of the internal surface of a typical human nostril with substantially homogeneous illumination intensity. The LEDs may be arranged in any suitable manner on base 40, for example in one or more concentric circles. It will be understood that, generally, the number of LEDs included in LED pack 20 of FIG. 2 controls the light output intensity of light source 1 (FIG. 1).
It will be appreciated that each of LEDs 4 emits a cone of light, and the LEDs are configured and arranged such that the plurality of cones of light emitted by the plurality of LEDs intersects over zone 42, such that more than one of LEDs 4 illuminate a common area of zone 42. Preferably, every point of zone 42 is illuminated by more than one of LEDs 4.
During operation, amplitude and/or duty cycle variation circuit 12 provides a DC voltage with variable amplitude and/or duty cycle between high voltage supply rail 28 and ground terminal 30. Thus, by varying the setting of amplitude/duty cycle variation circuit 12, the overall current flowing through LED pack 20 may be varied and, thereby, the light intensity provided by light source 1 is varied. As mentioned above, it is preferred that variation circuit 12 is set to a substantially continuous-wave mode of operation.
A preferred power level is between 1-30 mW/cm2, for example 10 mW/cm2.
Thus, the invention affords low cost apparatus for treating rhinitis by producing a non-coherent source of illumination, preferably in CW mode, which is focussed over a predefined area. In a preferred embodiment of the invention, the exact wavelength of the illumination is confined to a relatively narrow bandwidth (±25 nm) centered at a wavelength which may be predetermined and provided by suitable selection of LEDs 4 in LED pack 20. Experimental evidence indicates that red light, particularly 660 nm light, is particularly suitable for the treatment of rhinitis. The average intensity of the emitted illumination may be varied by the operator, and the therapy duration may be preset by means of the integral timer circuit 10.
Reference is now made to FIG. 4 which schematically illustrates an alternative, preferred, embodiment of the invention which may be particularly useful for patients requiring repeated treatment over prolonged periods of time. According to this embodiment, at least one light source 1 is securely, yet adjustably, mounted on a generally rigid support arrangement 70 which is mounted, in turn, on the face of a user. Support arrangement 70 preferably includes two ear supports 72 and a nose-top support 74, such as the ear and nose supports of eye glasses, so as to provide secure mounting of arrangement 70 on the face of the user. Each of the at least one light sources 1 is preferably mounted on an adjustable downward extension 76 of arrangement 70. FIG. 4 shows two light sources 1 mounted on two, respective, extensions 76 of arrangement 70, which are adjusted such that light sources 1 operatively engage the two nostrils of the user, respectively.
Light sources 1 are preferably powered and controlled, via suitable wires 75, by a control unit 78, similar to control unit 2 (FIGS. 1-3) but adapted to power and control more than one light source 1. Control unit 78 may be hand held or mounted to any suitable location on the user or placed at any other suitable location. Using this preferred embodiment of the invention, biostimulative illumination treatment as described above may be conveniently applied to both nostrils simultaneously.
Reference is now made to FIG. 5 which schematically illustrates another alternative, preferred, embodiment of the invention, wherein light source 1 and control unit 2 (FIGS. 1-3) are integrated into a single light treatment device 80. Treatment device 80 preferably includes an elongated, preferably pen-shaped, housing 82 which encloses circuitry substantially equivalent to that of control unit 2 and light source 1. A LED pack 84, which may be identical to LED pack 20 (FIG. 3), is disposed at one end of housing 82 and connected to the circuitry in housing 82 in the manner described above with reference to FIG. 2.
During operation, treatment device 80 may be hand held by the user, preferably at a prescribed position suitable for biostimulative illumination treatment. When device 80 is properly positioned, LED pack 84 operatively engages a rhinitis affected nostril for biostimulative treatment thereof, as described above with reference to FIGS. 1-3. Device 80 is preferably powered by a compact power source, such as a lithium battery.
It will be appreciated that the particular features of the methods and apparatus shown and described herein may be employed separately or in combination in any suitable manner so as to enhance efficacy of treatment.
Devices for treatment by illumination are disclosed in Published UK application GB 2212010A. However, it is believed that the embodiments described hereinabove, with reference to FIGS. 1-5, are preferred embodiments for treatment of rhinitis.
Experimental results indicate that most effective treatment of rhinitis symptoms, particularly those associated with the nostrils, is achieved when using light in the red bandwidth illuminated in a CW mode of operation. The experiments show a success rate of approximately 70 percent in relieving rhinitis symptoms, such as runny and/or itchy noses and post nasal drainage of mucus.
A preferred rhinitis treatment session, derived from actual experimental trials, will now be described. In a preferred embodiment of the invention, as shown in FIG. 3, LED pack 20 of light source 1 is preferably inserted to one of nostrils 50 of a rhinitis-suffering human nose 60 and, then, activated for a preselected treatment duration, for example three minutes. Then, light source 1 is removed from the treated nostril 50 and inserted to the other, untreated, nostril 50 for substantially the same treatment. This completes one rhinitis treatment session. For best results, the session described above is performed repeatedly, a number of times each day, over long periods of time, typically a few months.
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention is defined only by the claims that follow:

Claims (28)

We claim:
1. A method of treating allergic rhinitis comprising the steps of:
(a) providing at least one light emitting diode which emits non-coherent light radiation having a narrow bandwidth centered at a red light wavelength suitable for rhinitis treatment;
(b) driving the at least one light emitting diode to emit the non-coherent light radiation;
(c) illuminating a rhinitis affected zone of the interior of a nostril with the non-coherent light radiation without simultaneously illuminating the zone with non-coherent light emitting diode radiation in a bandwidth centered about a different wavelength; and
(d) maintaining the light radiation for a prescribed treatment duration.
2. A method of treating allergic rhinitis in accordance with claim 1 wherein the step of providing includes providing a plurality of light emitting diodes with each light emitting diode emitting non-coherent light radiation having a narrow bandwidth centered at the same red light wavelength, the step of driving including driving the plurality of light emitting diodes, the rhinitis affected zone of the interior of a nostril having at least one common area, the step of illuminating the rhinitis affected zone comprising simultaneously illuminating the common area with light radiation from at least two of the light emitting diodes of the plurality.
3. A method of treating allergic rhinitis in accordance with claim 2 wherein the step of driving comprises driving the light emitting diodes in a continuous wave mode.
4. A method of treating allergic rhinitis in accordance with claim 2 wherein two nostrils include rhinitis affected zones, the step of illuminating comprising simultaneously illuminating a rhinitis affected zone in each nostril.
5. A method of treating allergic rhinitis in accordance with claim 1 wherein the step of driving comprises driving the at least one light emitting diode in a continuous wave mode.
6. A method of treating allergic rhinitis in accordance with claim 1 wherein the step of illuminating includes the step of positioning at least a portion of the at least one light emitting diode into the nostril.
7. A method of treating allergic rhinitis in accordance with claim 1 wherein the step of illuminating further includes the step of concentrating the emitted light radiation in the interior of the nostril.
8. A method of treating allergic rhinitis in accordance with claim 7 wherein the step of concentrating includes positioning at least a portion of the at least one light emitting diode in the interior of the nostril.
9. A method of treating allergic rhinitis in accordance with claim 1 wherein the light radiation is emitted at a narrow bandwidth centered at a wavelength of approximately 660 nm.
10. A method of treating allergic rhinitis in accordance with claim 1 wherein the step of illuminating a rhinitis affected zone includes illuminating the zone at a power concentration level of between approximately one milliwatt per square centimeter and approximately thirty milliwatts per square centimeter.
11. A method of treating allergic rhinitis in accordance with claim 1 wherein the prescribed treatment duration is in the order of three minutes.
12. A method of treating rhinitis in accordance with claim 1 wherein the narrow bandwidth is in the order of ±25 nm.
13. A biostimulative illumination system for the treatment of rhinitis, the system comprising a power source, a plurality of light emitting diodes, each diode emitting non-coherent light radiation having a narrow bandwidth centered at a red light wavelength suitable for biostimulative rhinitis treatment and a driver, the driver driving the light emitting diodes to emit the non-coherent light radiation, the power source being operatively connected to the driver and the plurality of light emitting diodes being operatively connected to the driver, the system further including a housing, the plurality of light emitting diodes being arranged at one end of the housing, wherein the plurality of diodes are arranged such that their longitudinal axes are other than diverging, with the light radiation from each diode being directed to a common zone, the plurality of diodes being dimensioned and configured to permit insertion into the base of a nostril afflicted with rhinitis, the one end of the housing emitting light radiation only from the plurality of diodes and only in the narrow bandwidth centered at the red light wavelength, the common zone comprising a rhinitis afflicted region of the nostril when said plurality of diodes are inserted into the base of the nostril.
14. A biostimulative illumination system for treatment of rhinitis as constructed in accordance with claim 13 wherein the means for driving the light emitting diodes is carried within the housing.
15. A self contained portable biostimulative illumination system for treatment of rhinitis as constructed in accordance with claim 14 wherein the power source comprises a battery and is carried within the housing, the housing being substantially cylindrical and elongate.
16. A self contained portable biostimulative illumination system for treatment of rhinitis as constructed in accordance with claim 15 wherein the elongated cylindrical housing includes a pocket clip in simulation of a pen.
17. A biostimulative illumination system for treatment of rhinitis as constructed in accordance with claim 13 further including means for supporting the housing in an operative position wherein the light emitting diodes are positioned substantially within the nostril.
18. A biostimulative illumination system for treatment of rhinitis, the system comprising light emitting diode means for generating non-coherent light radiation having a narrow bandwidth centered at a wavelength suitable for rhinitis treatment, means for carrying the light emitting diode means and hands-free support means for positioning and maintaining the light emitting diode means in a fixed position at a base of a rhinitis afflicted nostril of a user for illuminating a rhinitis affected zone of an interior of the nostril, the system further including a driver for driving the light emitting diode means to emit the non-coherent light radiation on the rhinitis affected zone of the interior of the afflicted nostril.
19. A biostimulative illumination system for treatment of rhinitis in accordance with claim 18 including further light emitting diode means for generation non-coherent light radiation having a narrow bandwidth centered at a wavelength suitable for rhinitis treatment, means for carrying the further light emitting diode means and support means including means for positioning and maintaining each light emitting diode means at a base of a separate rhinitis afflicted nostril of the user.
20. A biostimulative illumination system for treatment of rhinitis in accordance with claim 19 wherein each light emitting diode means comprises a plurality of light emitting diodes.
21. A biostimulative illumination system for treatment of rhinitis in accordance with claim 18 wherein the light emitting diode means comprises a plurality of light emitting diodes.
22. A biostimulative illumination system for the treatment of rhinitis in accordance with claim 18, the hands-free support means including means for engaging an exterior portion of the user's head an means interconnecting the engaging means and the means carrying the light emitting diode means.
23. A method of treatment rhinitis in accordance with claim 1 further including the step of:
(e) repeating step (b), step (c) and step (d) at least once during a single day.
24. A method of treating allergic rhinitis in accordance with claim 23 wherein the step of repeating step (b), step (c) and step (d) is performed several times during a single day.
25. A method of treating allergic rhinitis in accordance with claim 24 wherein the step of repeating step (b), step (c) and step (d) is performed several times during a single day over a period of at least one month.
26. A method of treating allergic rhinitis in accordance with claim 23 wherein the step of repeating step (b), step (c) and step (d) is performed until the rhinitis symptoms are alleviated.
27. A biostimulative illumination system for the treatment of rhinitis, the system comprising a power source, a plurality of light emitting diodes, each diode emitting non-coherent light radiation having a narrow bandwidth centered at a red light wavelength suitable for biostimulative rhinitis treatment and means for driving the light emitting diodes to emit the non-coherent light radiation, the power source being operatively connected to the means for driving and the plurality of light emitting diodes being operatively connected to the means for driving, the system further including a housing, means for mounting the plurality of light emitting diodes in a pack at one end of the housing, the pack having a maximum transverse dimension configured to permit insertion of the pack into a nostril afflicted with rhinitis and means for supporting the housing in an operative position, the means for supporting including ear support means for engagement with an ear of the user and means interconnecting the ear support means with the housing.
28. A biostimulative illumination system for treatment of rhinitis as constructed in accordance with claim 27 wherein the means for supporting the housing includes nose support means configured for engagement with the exterior of the user's nose adjacent a bridge portion thereof and means interconnecting the nose support means with the housing.
US08/292,717 1994-02-24 1994-08-18 Treatment of rhinitis by biostimulative illumination Expired - Lifetime US5683436A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL108772 1994-02-24
IL10877294A IL108772A0 (en) 1994-02-24 1994-02-24 Treatment of rhinitis by biostimulative illumination

Publications (1)

Publication Number Publication Date
US5683436A true US5683436A (en) 1997-11-04

Family

ID=11065855

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/292,717 Expired - Lifetime US5683436A (en) 1994-02-24 1994-08-18 Treatment of rhinitis by biostimulative illumination

Country Status (5)

Country Link
US (1) US5683436A (en)
EP (1) EP0672435A1 (en)
JP (1) JP3635108B2 (en)
CA (1) CA2130308A1 (en)
IL (1) IL108772A0 (en)

Cited By (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820625A (en) * 1996-09-26 1998-10-13 Ya-Man Ltd. Light depilating apparatus
US6022479A (en) * 1998-07-22 2000-02-08 Smirnov; Igor Method and device for producing activated liquids and methods of use thereof
US6221095B1 (en) * 1996-11-13 2001-04-24 Meditech International Inc. Method and apparatus for photon therapy
WO2001047447A1 (en) * 1999-12-28 2001-07-05 Sergei Ivanovich Nefedov Device for photothermocryotherapy and method for the application thereof
KR20020017235A (en) * 2000-08-29 2002-03-07 안성준 Optical Condensation Apparatus for Medical Treatment
US6428180B1 (en) 1999-07-20 2002-08-06 Mickey M. Karram Surgical illumination device and method of use
US6500198B1 (en) 1999-10-04 2002-12-31 Barbara L. Southard Crystal quartz scepter
US20030009205A1 (en) * 1997-08-25 2003-01-09 Biel Merrill A. Treatment device for topical photodynamic therapy and method of using same
US20040054386A1 (en) * 2002-09-04 2004-03-18 Todd Martin Device for the treatment of muscle or joint pain
US20040204747A1 (en) * 2001-08-10 2004-10-14 Lajos Kemeny Phototherapeutical apparatus and method for the treatment and prevention of diseases of body cavities
US20050107853A1 (en) * 2003-10-15 2005-05-19 Yosef Krespi Control of rhinosinusitis-related, and other microorganisms in the sino-nasal tract
US20060100679A1 (en) * 2004-08-27 2006-05-11 Dimauro Thomas Light-based implants for treating Alzheimer's disease
US20060173514A1 (en) * 2005-02-02 2006-08-03 Advanced Photodynamic Technologies, Inc. Wound treatment device for photodynamic therapy and method of using same
US20060200212A1 (en) * 2005-02-17 2006-09-07 Brawn Peter R Light therapy device for treatment of bone disorders and biostimulation of bone and soft tissue
US20060235493A1 (en) * 2005-04-14 2006-10-19 Dotson Robert S Ophthalmic phototherapy device and associated treatment method
US20060287695A1 (en) * 2005-06-16 2006-12-21 Dimauro Thomas M Intranasal red light probe for treating Alzheimer's disease
US20060287696A1 (en) * 2005-06-21 2006-12-21 Wright David W Heat and light therapy treatment device and method
US20070098645A1 (en) * 2005-10-31 2007-05-03 Agbodoe Victor B Intranasal delivery of compounds that reduce intrancranial pressure
US20070239235A1 (en) * 2005-03-14 2007-10-11 Dimauro Thomas M Red Light Implant For Treating Parkinson's Disease
US20070239233A1 (en) * 2006-04-07 2007-10-11 Life Without Pain L.L.C. Surface mount light emitting diode medical apparatus
US20070248930A1 (en) * 2005-02-17 2007-10-25 Biolux Research Ltd. Light therapy apparatus and methods
US20070255356A1 (en) * 2006-04-28 2007-11-01 Ondine International, Ltd. Photodisinfection delivery devices and methods
US20070282401A1 (en) * 2006-04-27 2007-12-06 Meditech International Inc Controller
US20080009839A1 (en) * 2005-04-14 2008-01-10 Dotson Robert S Ophthalmic Phototherapy Device and Associated Treatment Method
US20080033512A1 (en) * 2006-08-01 2008-02-07 Mesure Technology Co., Ltd. Light Therapy Device
US20080269730A1 (en) * 2005-04-14 2008-10-30 Dotson Robert S Ophthalmic Phototherapy Device and Associated Treatment Method
US7559945B2 (en) 2006-01-13 2009-07-14 Clarimedix Inc. Multi-spectral photon therapy device and methods of use
US20090319008A1 (en) * 2005-03-31 2009-12-24 Esther Mayer Probe device, system and method for photobiomodulation of tissue lining a body cavity
US20100198316A1 (en) * 2009-02-04 2010-08-05 Richard Toselli Intracranial Red Light Treatment Device For Chronic Pain
WO2011067752A1 (en) 2009-12-02 2011-06-09 Joseph Feldman Device used for treatment of rhinitis by biostimulative illumination
US8109981B2 (en) 2005-01-25 2012-02-07 Valam Corporation Optical therapies and devices
US8996137B2 (en) 2013-04-19 2015-03-31 Oculeve, Inc. Nasal stimulation devices and methods
US9242118B2 (en) 2010-12-08 2016-01-26 Biolux Research Ltd. Methods useful for remodeling maxillofacial bone using light therapy and a functional appliance
US9265967B2 (en) 2011-08-05 2016-02-23 Lumimed, Llc Apparatus and method for treating rhinitis
US20160095180A1 (en) * 2004-02-25 2016-03-31 Lynk Labs, Inc. LED Lighting System
US9320914B2 (en) 2008-03-03 2016-04-26 DePuy Synthes Products, Inc. Endoscopic delivery of red/NIR light to the subventricular zone
US20160166847A1 (en) * 2014-05-13 2016-06-16 Hl&P Co., Ltd. Light therapy device for rhinitis or tympanitis treatment
US9592404B2 (en) 2005-04-14 2017-03-14 Photospectra Health Sciences, Inc. Ophthalmic phototherapy device and associated treatment method
US9687652B2 (en) 2014-07-25 2017-06-27 Oculeve, Inc. Stimulation patterns for treating dry eye
WO2017117634A1 (en) * 2016-01-06 2017-07-13 Cosmetic Edge Pty Ltd Phototherapy system for treating nasal disorders
US9730780B2 (en) 2013-10-22 2017-08-15 Biolux Research Ltd. Intra-oral light-therapy apparatuses and methods for their use
US9737712B2 (en) 2014-10-22 2017-08-22 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US20170238871A1 (en) * 2004-08-11 2017-08-24 University Of Florida Research Foundation, Inc. Novel pulse oximeter probes and methods for using the same
US9770583B2 (en) 2014-02-25 2017-09-26 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
EP3222314A1 (en) 2016-03-21 2017-09-27 Joseph Feldman Nasal spray apparatus
USD826420S1 (en) 2014-04-18 2018-08-21 Oculeve, Inc. Nasal stimulator device
US10154551B2 (en) 2004-02-25 2018-12-11 Lynk Labs, Inc. AC light emitting diode and AC LED drive methods and apparatus
CN109172340A (en) * 2018-10-16 2019-01-11 泗水县人民医院 A kind of rhinitis fumigation treatment device
US10207108B2 (en) 2014-10-22 2019-02-19 Oculeve, Inc. Implantable nasal stimulator systems and methods
USRE47266E1 (en) 2005-03-14 2019-03-05 DePuy Synthes Products, Inc. Light-based implants for treating Alzheimer's disease
US10219944B2 (en) 2014-09-09 2019-03-05 LumiThera, Inc. Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
US10328262B2 (en) 2010-11-16 2019-06-25 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
US10537469B2 (en) 2013-03-12 2020-01-21 Oculeve, Inc. Implant delivery devices, systems, and methods
US10610095B2 (en) 2016-12-02 2020-04-07 Oculeve, Inc. Apparatus and method for dry eye forecast and treatment recommendation
US10610695B2 (en) 2014-10-22 2020-04-07 Oculeve, Inc. Implantable device for increasing tear production
US10695577B2 (en) 2001-12-21 2020-06-30 Photothera, Inc. Device and method for providing phototherapy to the heart
US10722718B2 (en) 2010-11-16 2020-07-28 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US10758743B2 (en) 2001-11-01 2020-09-01 Pthera LLC Method for providing phototherapy to the brain
US10881872B1 (en) * 2010-08-05 2021-01-05 Richard Oberreiter Apparatus and methods for controlling and applying flash lamp radiation
US10918864B2 (en) 2016-05-02 2021-02-16 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
US11147984B2 (en) 2020-03-19 2021-10-19 Know Bio, Llc Illumination devices for inducing biological effects
US20220152418A1 (en) * 2019-03-08 2022-05-19 Peach Tech Rhinitis treatment device
US11524173B2 (en) 2015-07-28 2022-12-13 Know Bio, Llc Systems and methods for phototherapeutic modulation of nitric oxide
US11654294B2 (en) 2021-03-15 2023-05-23 Know Bio, Llc Intranasal illumination devices
US11801396B1 (en) * 2020-03-10 2023-10-31 Cosmo Haralambidis Wearable device including UVC light source for reduction in virus and bacteria transmission

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728090A (en) * 1995-02-09 1998-03-17 Quantum Devices, Inc. Apparatus for irradiating living cells
GB2329756A (en) 1997-09-25 1999-03-31 Univ Bristol Assemblies of light emitting diodes
US6200134B1 (en) 1998-01-20 2001-03-13 Kerr Corporation Apparatus and method for curing materials with radiation
AT409089B (en) * 1999-03-23 2002-05-27 Leopold Dr Nidetzky Laser unit for biostimulation
IT1309464B1 (en) * 1999-12-10 2002-01-23 Rgm Spa LASER THERAPY APPARATUS.
DE10120629A1 (en) * 2001-04-26 2002-10-31 Michael Lenke irradiator
KR101047246B1 (en) 2002-07-25 2011-07-06 조나단 에스. 담 Method and apparatus for using curing LED
KR101277642B1 (en) * 2004-11-20 2013-06-21 에라스무스 유니버시티 메디컬 센터 로테르담 Device and method for photodynamic therapy of the nasopharyngeal cavity
KR100685445B1 (en) * 2006-02-09 2007-02-26 김병수 Apparatus for rhinitis curing
US8047686B2 (en) 2006-09-01 2011-11-01 Dahm Jonathan S Multiple light-emitting element heat pipe assembly
KR100935805B1 (en) * 2007-11-21 2010-01-06 단국대학교 산학협력단 Laser Irradiation Apparatus of The Nasal Cavity Burying Style
KR20100138922A (en) 2008-02-13 2010-12-31 안드레아스 로즈 Light delivery device that provides a radial light output pattern
KR100987729B1 (en) * 2008-05-16 2010-10-13 전남대학교산학협력단 apparatus for curing rhinitis using LED
SK5457Y1 (en) * 2008-10-21 2010-06-07 Yalong Trade S R O Nasal applicator for intranasal laser irradiation of blood
JP5147949B2 (en) * 2008-10-30 2013-02-20 株式会社日立製作所 Biological light measurement device
GB0900461D0 (en) * 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
KR101019464B1 (en) * 2009-03-25 2011-03-07 한국과학기술연구원 Optical stimulation system
US9066777B2 (en) 2009-04-02 2015-06-30 Kerr Corporation Curing light device
US9072572B2 (en) 2009-04-02 2015-07-07 Kerr Corporation Dental light device
DE102011051147B4 (en) * 2011-06-17 2015-03-12 Herbert Friede Light-emitting body and device for illumination during photodisinfection
JP2014223189A (en) * 2013-05-16 2014-12-04 克仁 阿部 Method for inhibiting pollinosis
JP6195268B2 (en) * 2013-07-18 2017-09-13 国立大学法人徳島大学 Rhinitis prevention and treatment equipment

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2212016A (en) * 1987-10-30 1989-07-12 Teradyne Inc Calibration of digital to analog converters
US4926880A (en) * 1988-11-08 1990-05-22 Microcurrents Method for relieving sinus and nasal congestion utilizing microcurrents
US4930504A (en) * 1987-11-13 1990-06-05 Diamantopoulos Costas A Device for biostimulation of tissue and method for treatment of tissue
US4931053A (en) * 1988-01-27 1990-06-05 L'esperance Medical Technologies, Inc. Method and apparatus for enhanced vascular or other growth
US4963798A (en) * 1989-02-21 1990-10-16 Mcdermott Kevin Synthesized lighting device
US5259380A (en) * 1987-11-04 1993-11-09 Amcor Electronics, Ltd. Light therapy system
US5304207A (en) * 1992-02-05 1994-04-19 Merrill Stromer Electrostimulator with light emitting device
WO1994015666A1 (en) * 1993-01-13 1994-07-21 Pdt Systems, Inc. Light emitting diode source for photodynamic therapy
US5335659A (en) * 1993-04-12 1994-08-09 Ohmeda Inc. Nasal septum probe for photoplethysmographic measurements
US5358503A (en) * 1994-01-25 1994-10-25 Bertwell Dale E Photo-thermal therapeutic device and method
US5384693A (en) * 1992-04-14 1995-01-24 Vereinigte Drahtwerke A.G. Tail light for a bicycle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR644157A (en) * 1926-11-24 1928-10-03 Device for the treatment of mucous membranes
DE3023130A1 (en) * 1980-06-20 1982-01-21 Hasso von 4000 Düsseldorf Blücher Mouth and nose steriliser - uses high intensity light flash of millisecond duration
US4646743A (en) * 1984-05-09 1987-03-03 Parris Danny M Therapy radiation apparatus for veterinary medicine

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2212016A (en) * 1987-10-30 1989-07-12 Teradyne Inc Calibration of digital to analog converters
US5259380A (en) * 1987-11-04 1993-11-09 Amcor Electronics, Ltd. Light therapy system
US4930504A (en) * 1987-11-13 1990-06-05 Diamantopoulos Costas A Device for biostimulation of tissue and method for treatment of tissue
US4931053A (en) * 1988-01-27 1990-06-05 L'esperance Medical Technologies, Inc. Method and apparatus for enhanced vascular or other growth
US4926880A (en) * 1988-11-08 1990-05-22 Microcurrents Method for relieving sinus and nasal congestion utilizing microcurrents
US4963798A (en) * 1989-02-21 1990-10-16 Mcdermott Kevin Synthesized lighting device
US5304207A (en) * 1992-02-05 1994-04-19 Merrill Stromer Electrostimulator with light emitting device
US5384693A (en) * 1992-04-14 1995-01-24 Vereinigte Drahtwerke A.G. Tail light for a bicycle
WO1994015666A1 (en) * 1993-01-13 1994-07-21 Pdt Systems, Inc. Light emitting diode source for photodynamic therapy
US5335659A (en) * 1993-04-12 1994-08-09 Ohmeda Inc. Nasal septum probe for photoplethysmographic measurements
US5358503A (en) * 1994-01-25 1994-10-25 Bertwell Dale E Photo-thermal therapeutic device and method

Non-Patent Citations (35)

* Cited by examiner, † Cited by third party
Title
A Possible Explanation of Laser Induced Stimulation Friedman, H.; Lubart, R. and Laulicht, I.; Journal Photochemistry B; Biol (1991) 87 95. *
A Possible Explanation of Laser Induced Stimulation Friedman, H.; Lubart, R. and Laulicht, I.; Journal Photochemistry B; Biol (1991) 87-95.
Abstract, Kaiser et al, "Helium-Neon Laser radiation versus Placebo in the treatment of Acute Maxillary Sinusitis", Av Odontoestoestomatol, Mar.-Apr. 1987, vol. 3, No. 2, pp. 73-76.
Abstract, Kaiser et al, Helium Neon Laser radiation versus Placebo in the treatment of Acute Maxillary Sinusitis , Av Odontoestoestomatol, Mar. Apr. 1987, vol. 3, No. 2, pp. 73 76. *
Abstract, Kruchinina et al, "Effect of Laser Therapy on Local Immunoglobin Synthesis in Children with Acute or Chronic Maxillary Sinusitis," Vestn Otorinolaringiolog, vol. 2, 1988, pp. 19-21.
Abstract, Kruchinina et al, Effect of Laser Therapy on Local Immunoglobin Synthesis in Children with Acute or Chronic Maxillary Sinusitis, Vestn Otorinolaringiolog, vol. 2, 1988, pp. 19 21. *
Abstract, Moustsen et al "Laser Treatment of Sinusitis in General Practice Assessed by Double-Blind Controlled Study", Egeskr Laeger, Aug. 5, 1991, vol. 153(32) pp. 2232-2234.
Abstract, Moustsen et al Laser Treatment of Sinusitis in General Practice Assessed by Double Blind Controlled Study , Egeskr Laeger, Aug. 5, 1991, vol. 153(32) pp. 2232 2234. *
Abstract, Pluzhnikov, "Use of Intracavity Low-Energy Laser Theray in the Complex Treatment of Inflammatory Diseases of the Sphenoid Sinus", Vestn Otorinolaringoliolog, vol. 4, Jul.-Aug. 1986, pp. 72-73.
Abstract, Pluzhnikov, Use of Intracavity Low Energy Laser Theray in the Complex Treatment of Inflammatory Diseases of the Sphenoid Sinus , Vestn Otorinolaringoliolog, vol. 4, Jul. Aug. 1986, pp. 72 73. *
American Society for Laser Medicine and Surgery Abstracts Lasers in Surgery and Medicine, Supplement 3, 1991 pp. 9 12. *
American Society for Laser Medicine and Surgery Abstracts Lasers in Surgery and Medicine, Supplement 3, 1991 pp. 9-12.
Benefit/Risk Ratio of the Antihistamines . . . (Medline abstract) Simons FE; Reggin JD; Roberts JR; Simons KJ J Pediatr. 1994 Jun; 124 (6) : 979 83. *
Benefit/Risk Ratio of the Antihistamines . . . (Medline abstract) Simons-FE; Reggin-JD; Roberts-JR; Simons-KJ J-Pediatr. 1994 Jun; 124 (6) : 979-83.
Changes in Oxidative Metabolism of Murine . . . (Medline abstract) Karu T; Andreichuk T; Ryabykh T Lasers Surg Med. 1993; 13 (4): 453 62. *
Changes in Oxidative Metabolism of Murine . . . (Medline abstract) Karu-T; Andreichuk-T; Ryabykh-T Lasers-Surg-Med. 1993; 13 (4): 453-62.
Effect of Low Power Density Laser Radiation . . . (Medline abstract) Kana JS; Hutschenreiter G; Haina D; Waidelich W Arch Surg. 1981 Mar.; 116(3) : 293 6. *
Effect of Low-Power Density Laser Radiation . . . (Medline abstract) Kana-JS; Hutschenreiter-G; Haina-D; Waidelich-W Arch-Surg. 1981 Mar.; 116(3) : 293-6.
Effects of Visible and Near Infrared Lasers . . . (Medline abstract) Lubart R; Wollman Y; Friedman H; Rochkind S; Laulicht I J Photochem Photobiol B. 1992 Feb. 28: 12 (3) : 305 310. *
Effects of Visible and Near-Infrared Lasers . . . (Medline abstract) Lubart-R; Wollman-Y; Friedman-H; Rochkind-S; Laulicht-I J-Photochem-Photobiol-B. 1992 Feb. 28: 12 (3) : 305-310.
Endoscopic Endonasal Surgery . . . (Medline abstract) Stammberger H Otolaryngol Head Neck Surg. 1986 Feb.; 94 (2): 143 7. *
Endoscopic Endonasal Surgery . . . (Medline abstract) Stammberger-H Otolaryngol-Head-Neck-Surg. 1986 Feb.; 94 (2): 143-7.
Macrophage Responsiveness to Light Therapy Young, S.; Bolton, P.; Dyson, M. et al. Lasers in Surgery and Medicine 9:487 505 (1989). *
Macrophage Responsiveness to Light Therapy Young, S.; Bolton, P.; Dyson, M. et al. Lasers in Surgery and Medicine 9:487-505 (1989).
Molecular Mechanism of Therapeutic Effect of Low Intensity Laser Radiation Karu, T.I.; Lasers in Life Sciences 2 (1) 1988 pp.53 74. *
Molecular Mechanism of Therapeutic Effect of Low Intensity Laser Radiation Karu, T.I.; Lasers in Life Sciences 2 (1) 1988 pp.53-74.
Photobiological Basis of Low Level Laser Radiation Therapy. *
Photoreactivation of Superoxide Dismutase . . . (Medline abstract) Vladimirov YA; Gorbatenkova EA; Paramonov NV; Azizova OA Free Radic Biol Med. 1988; 5 (5 6): 281 6. *
Photoreactivation of Superoxide Dismutase . . . (Medline abstract) Vladimirov-YA; Gorbatenkova-EA; Paramonov-NV; Azizova-OA Free-Radic-Biol-Med. 1988; 5 (5-6): 281-6.
The Biomedical Effects of Laser Application Mester, Andre; Mester, Andrew and Mester, Adam; Lasers in Surgery and Medicine 5:31 39 (1985). *
The Biomedical Effects of Laser Application Mester, Andre; Mester, Andrew and Mester, Adam; Lasers in Surgery and Medicine 5:31-39 (1985).
The In vivo nerve Response to Direct Low Energy Laser . . . (Medline abstract) Rochkind S; Nissan M; Lubart R; Avram J; Bartal A Acta Neurochir Wien. 1988; 94(1 2) : 74 7. *
The In-vivo-nerve Response to Direct Low-Energy-Laser . . . (Medline abstract) Rochkind-S; Nissan-M; Lubart-R; Avram-J; Bartal-A Acta-Neurochir-Wien. 1988; 94(1-2) : 74-7.
Towards an Explanation of Visible and Infrared Laser Induced Stimulation . . . Friedman, H. and Lubart, R.; Laser Therapy (1992) pp. 39 42. *
Towards an Explanation of Visible and Infrared Laser Induced Stimulation . . . Friedman, H. and Lubart, R.; Laser Therapy (1992) pp. 39-42.

Cited By (130)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820625A (en) * 1996-09-26 1998-10-13 Ya-Man Ltd. Light depilating apparatus
US6221095B1 (en) * 1996-11-13 2001-04-24 Meditech International Inc. Method and apparatus for photon therapy
US20030009205A1 (en) * 1997-08-25 2003-01-09 Biel Merrill A. Treatment device for topical photodynamic therapy and method of using same
US7070611B2 (en) 1997-08-25 2006-07-04 Advanced Photodynamic Technologies, Inc. Treatment device for topical photodynamic therapy and method of using same
US6022479A (en) * 1998-07-22 2000-02-08 Smirnov; Igor Method and device for producing activated liquids and methods of use thereof
US6428180B1 (en) 1999-07-20 2002-08-06 Mickey M. Karram Surgical illumination device and method of use
US6500198B1 (en) 1999-10-04 2002-12-31 Barbara L. Southard Crystal quartz scepter
WO2001047447A1 (en) * 1999-12-28 2001-07-05 Sergei Ivanovich Nefedov Device for photothermocryotherapy and method for the application thereof
KR20020017235A (en) * 2000-08-29 2002-03-07 안성준 Optical Condensation Apparatus for Medical Treatment
US20060111760A1 (en) * 2001-08-10 2006-05-25 Lajos Kemeny Phototherapeutical method and system for the treatment of inflammatory and hyperproliferative disorders of the nasal mucosa
US20040204747A1 (en) * 2001-08-10 2004-10-14 Lajos Kemeny Phototherapeutical apparatus and method for the treatment and prevention of diseases of body cavities
US7226470B2 (en) * 2001-08-10 2007-06-05 Rhinolight Corporation Phototherapeutical apparatus and method for the treatment and prevention of diseases of body cavities
US10758743B2 (en) 2001-11-01 2020-09-01 Pthera LLC Method for providing phototherapy to the brain
US10695577B2 (en) 2001-12-21 2020-06-30 Photothera, Inc. Device and method for providing phototherapy to the heart
US20040054386A1 (en) * 2002-09-04 2004-03-18 Todd Martin Device for the treatment of muscle or joint pain
US20050107853A1 (en) * 2003-10-15 2005-05-19 Yosef Krespi Control of rhinosinusitis-related, and other microorganisms in the sino-nasal tract
US7435252B2 (en) * 2003-10-15 2008-10-14 Valam Corporation Control of microorganisms in the sino-nasal tract
US10652979B2 (en) 2004-02-25 2020-05-12 Lynk Labs, Inc. LED lighting system
US20160095180A1 (en) * 2004-02-25 2016-03-31 Lynk Labs, Inc. LED Lighting System
US10492260B2 (en) 2004-02-25 2019-11-26 Lynk Labs, Inc. LED lighting system
US10334680B2 (en) 2004-02-25 2019-06-25 Lynk Labs, Inc. LED lighting system
US10904967B2 (en) 2004-02-25 2021-01-26 Lynk Labs, Inc. LED lighting system
US10517149B2 (en) 2004-02-25 2019-12-24 Lynk Labs, Inc. AC light emitting diode and AC LED drive methods and apparatus
US9615420B2 (en) * 2004-02-25 2017-04-04 Lynk Labs, Inc. LED lighting system
US10154551B2 (en) 2004-02-25 2018-12-11 Lynk Labs, Inc. AC light emitting diode and AC LED drive methods and apparatus
US10555385B2 (en) 2004-02-25 2020-02-04 Lynk Labs, Inc. LED lighting system
US10051703B2 (en) 2004-02-25 2018-08-14 Lynk Labs, Inc. LED lighting system
US11678420B2 (en) 2004-02-25 2023-06-13 Lynk Labs, Inc. LED lighting system
US11259749B2 (en) * 2004-08-11 2022-03-01 Koninklijke Philips N.V. Pulse oximeter probes and methods for using the same
US20170238871A1 (en) * 2004-08-11 2017-08-24 University Of Florida Research Foundation, Inc. Novel pulse oximeter probes and methods for using the same
US20060100679A1 (en) * 2004-08-27 2006-05-11 Dimauro Thomas Light-based implants for treating Alzheimer's disease
US8821559B2 (en) 2004-08-27 2014-09-02 Codman & Shurtleff, Inc. Light-based implants for treating Alzheimer's disease
US8109981B2 (en) 2005-01-25 2012-02-07 Valam Corporation Optical therapies and devices
US20060173514A1 (en) * 2005-02-02 2006-08-03 Advanced Photodynamic Technologies, Inc. Wound treatment device for photodynamic therapy and method of using same
US20060200212A1 (en) * 2005-02-17 2006-09-07 Brawn Peter R Light therapy device for treatment of bone disorders and biostimulation of bone and soft tissue
US20070248930A1 (en) * 2005-02-17 2007-10-25 Biolux Research Ltd. Light therapy apparatus and methods
US9308389B2 (en) 2005-02-17 2016-04-12 Biolux Research Ltd. Light therapy apparatus and methods
US8900282B2 (en) 2005-02-17 2014-12-02 Biolux Research Ltd. Light therapy apparatus and methods
US8900284B2 (en) 2005-03-14 2014-12-02 DePuy Synthes Products, LLC Red light implant for treating Parkinson's disease
USRE47266E1 (en) 2005-03-14 2019-03-05 DePuy Synthes Products, Inc. Light-based implants for treating Alzheimer's disease
US20070239235A1 (en) * 2005-03-14 2007-10-11 Dimauro Thomas M Red Light Implant For Treating Parkinson's Disease
US11173320B2 (en) 2005-03-31 2021-11-16 Esther Mayer Probe device, system and method for photobiomodulation of tissue lining a body cavity
US20090319008A1 (en) * 2005-03-31 2009-12-24 Esther Mayer Probe device, system and method for photobiomodulation of tissue lining a body cavity
US20080009839A1 (en) * 2005-04-14 2008-01-10 Dotson Robert S Ophthalmic Phototherapy Device and Associated Treatment Method
US10252078B2 (en) 2005-04-14 2019-04-09 Photospectra Health Sciences, Inc. Ophthalmic phototherapy method
US9782604B2 (en) 2005-04-14 2017-10-10 Photospectra Health Sciences, Inc. Ophthalmic phototherapy device and associated treatment method
US9814903B2 (en) 2005-04-14 2017-11-14 Photospectra Health Services, Inc. Ophthalmic phototherapy system and associated method
US9974971B2 (en) 2005-04-14 2018-05-22 Photospectra Health Sciences, Inc Ophthalmic phototherapy method
US9592405B2 (en) 2005-04-14 2017-03-14 Photospectra Health Sciences, Inc. Ophthalmic phototherapy device and associated treatment method
US9592404B2 (en) 2005-04-14 2017-03-14 Photospectra Health Sciences, Inc. Ophthalmic phototherapy device and associated treatment method
US7479136B2 (en) 2005-04-14 2009-01-20 Dotson Robert S Ophthalmic phototherapy treatment method
US20080269730A1 (en) * 2005-04-14 2008-10-30 Dotson Robert S Ophthalmic Phototherapy Device and Associated Treatment Method
US20060235493A1 (en) * 2005-04-14 2006-10-19 Dotson Robert S Ophthalmic phototherapy device and associated treatment method
US8734498B2 (en) 2005-06-16 2014-05-27 DePuy Synthes Products, LLC Intranasal red light probe for treating alzheimer's disease
US7351253B2 (en) * 2005-06-16 2008-04-01 Codman & Shurtleff, Inc. Intranasal red light probe for treating Alzheimer's disease
US20060287695A1 (en) * 2005-06-16 2006-12-21 Dimauro Thomas M Intranasal red light probe for treating Alzheimer's disease
US20110022130A1 (en) * 2005-06-16 2011-01-27 Dimauro Thomas M Intranasal Red Light Probe For Treating Alzheimer's Disease
US20060287696A1 (en) * 2005-06-21 2006-12-21 Wright David W Heat and light therapy treatment device and method
US20070098645A1 (en) * 2005-10-31 2007-05-03 Agbodoe Victor B Intranasal delivery of compounds that reduce intrancranial pressure
US8167920B2 (en) * 2005-10-31 2012-05-01 Codman & Shurtleff, Inc. Intranasal delivery of compounds that reduce intrancranial pressure
US7559945B2 (en) 2006-01-13 2009-07-14 Clarimedix Inc. Multi-spectral photon therapy device and methods of use
US20070239233A1 (en) * 2006-04-07 2007-10-11 Life Without Pain L.L.C. Surface mount light emitting diode medical apparatus
US20070282401A1 (en) * 2006-04-27 2007-12-06 Meditech International Inc Controller
US20070255356A1 (en) * 2006-04-28 2007-11-01 Ondine International, Ltd. Photodisinfection delivery devices and methods
US20080033512A1 (en) * 2006-08-01 2008-02-07 Mesure Technology Co., Ltd. Light Therapy Device
US8080047B2 (en) * 2006-08-01 2011-12-20 Mesure Technology Co., Ltd. Light therapy device
US10561857B2 (en) 2008-03-03 2020-02-18 DePuy Synthes Products, Inc. Method of treating traumatic brain injury with red/NIR light
US9320914B2 (en) 2008-03-03 2016-04-26 DePuy Synthes Products, Inc. Endoscopic delivery of red/NIR light to the subventricular zone
US20100198316A1 (en) * 2009-02-04 2010-08-05 Richard Toselli Intracranial Red Light Treatment Device For Chronic Pain
US8728136B2 (en) 2009-12-02 2014-05-20 Joseph Feldman Device used for treatment of rhinitis by biostimulative illumination
EA020906B1 (en) * 2009-12-02 2015-02-27 Джозеф Фельдман Device used for treatment of rhinitis by biostimulative illumination
CN102725025B (en) * 2009-12-02 2015-04-22 约瑟夫·菲尔德曼 Device used for treatment of rhinitis by biostimulative illumination
WO2011067752A1 (en) 2009-12-02 2011-06-09 Joseph Feldman Device used for treatment of rhinitis by biostimulative illumination
CN102725025A (en) * 2009-12-02 2012-10-10 约瑟夫·菲尔德曼 Device used for treatment of rhinitis by biostimulative illumination
US10881872B1 (en) * 2010-08-05 2021-01-05 Richard Oberreiter Apparatus and methods for controlling and applying flash lamp radiation
US10835748B2 (en) 2010-11-16 2020-11-17 Oculeve, Inc. Stimulation devices and methods
US11771908B2 (en) 2010-11-16 2023-10-03 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US10722718B2 (en) 2010-11-16 2020-07-28 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US10328262B2 (en) 2010-11-16 2019-06-25 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
US9242118B2 (en) 2010-12-08 2016-01-26 Biolux Research Ltd. Methods useful for remodeling maxillofacial bone using light therapy and a functional appliance
US20160166848A1 (en) * 2011-08-05 2016-06-16 Lumimed, Llc Device and method for treating allergic rhinitis
US10463872B2 (en) * 2011-08-05 2019-11-05 Lumimed, Llc Device and method for treating allergic rhinitis
US9265967B2 (en) 2011-08-05 2016-02-23 Lumimed, Llc Apparatus and method for treating rhinitis
US10537469B2 (en) 2013-03-12 2020-01-21 Oculeve, Inc. Implant delivery devices, systems, and methods
US9737702B2 (en) 2013-04-19 2017-08-22 Oculeve, Inc. Nasal stimulation devices and methods
US10155108B2 (en) 2013-04-19 2018-12-18 Oculeve, Inc. Nasal stimulation devices and methods
US10238861B2 (en) 2013-04-19 2019-03-26 Oculeve, Inc. Nasal stimulation devices and methods for treating dry eye
US8996137B2 (en) 2013-04-19 2015-03-31 Oculeve, Inc. Nasal stimulation devices and methods
US10799695B2 (en) 2013-04-19 2020-10-13 Oculeve, Inc. Nasal stimulation devices and methods
US9440065B2 (en) 2013-04-19 2016-09-13 Oculeve, Inc. Nasal stimulation devices and methods
US10835738B2 (en) 2013-04-19 2020-11-17 Oculeve, Inc. Nasal stimulation devices and methods
US10967173B2 (en) 2013-04-19 2021-04-06 Oculeve, Inc. Nasal stimulation devices and methods for treating dry eye
US9730780B2 (en) 2013-10-22 2017-08-15 Biolux Research Ltd. Intra-oral light-therapy apparatuses and methods for their use
US10729524B2 (en) 2013-10-22 2020-08-04 Biolux Research Holdings, Inc. Intra-oral light-therapy apparatuses and methods for their use
US9770583B2 (en) 2014-02-25 2017-09-26 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
US10799696B2 (en) 2014-02-25 2020-10-13 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
US9956397B2 (en) 2014-02-25 2018-05-01 Oculeve, Inc. Polymer Formulations for nasolacrimal stimulation
USD837396S1 (en) 2014-04-18 2019-01-01 Oculeve, Inc. Nasal stimulator probe
USD907791S1 (en) 2014-04-18 2021-01-12 Oculeve, Inc. Nasal stimulator body
USD826420S1 (en) 2014-04-18 2018-08-21 Oculeve, Inc. Nasal stimulator device
US10478636B2 (en) * 2014-05-13 2019-11-19 Evoray Co. Ltd. Light therapy device for rhinitis or tympanitis treatment
US20160166847A1 (en) * 2014-05-13 2016-06-16 Hl&P Co., Ltd. Light therapy device for rhinitis or tympanitis treatment
US9687652B2 (en) 2014-07-25 2017-06-27 Oculeve, Inc. Stimulation patterns for treating dry eye
US10722713B2 (en) 2014-07-25 2020-07-28 Oculeve, Inc. Stimulation patterns for treating dry eye
US10596037B2 (en) 2014-09-09 2020-03-24 LumiThera, Inc. Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments
US10219944B2 (en) 2014-09-09 2019-03-05 LumiThera, Inc. Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments
US10881550B2 (en) 2014-09-09 2021-01-05 LumiThera, Inc. Multi-wavelength phototherapy systems and methods for the treatment of damaged or diseased tissue
US10112048B2 (en) 2014-10-22 2018-10-30 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US10610695B2 (en) 2014-10-22 2020-04-07 Oculeve, Inc. Implantable device for increasing tear production
US9737712B2 (en) 2014-10-22 2017-08-22 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US10780273B2 (en) 2014-10-22 2020-09-22 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US10207108B2 (en) 2014-10-22 2019-02-19 Oculeve, Inc. Implantable nasal stimulator systems and methods
US11617895B2 (en) 2015-07-28 2023-04-04 Know Bio, Llc Systems and methods for phototherapeutic modulation of nitric oxide
US11524173B2 (en) 2015-07-28 2022-12-13 Know Bio, Llc Systems and methods for phototherapeutic modulation of nitric oxide
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
CN108778414A (en) * 2016-01-06 2018-11-09 艾奇化妆品私人有限公司 Photo-therapeutic system for treating nasal disease
WO2017117634A1 (en) * 2016-01-06 2017-07-13 Cosmetic Edge Pty Ltd Phototherapy system for treating nasal disorders
US10835410B2 (en) 2016-01-06 2020-11-17 Cosmetic Edge Pty Ltd Phototherapy system for treating nasal disorders
US10940310B2 (en) 2016-02-19 2021-03-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
EP3222314A1 (en) 2016-03-21 2017-09-27 Joseph Feldman Nasal spray apparatus
US10918864B2 (en) 2016-05-02 2021-02-16 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
US10610095B2 (en) 2016-12-02 2020-04-07 Oculeve, Inc. Apparatus and method for dry eye forecast and treatment recommendation
CN109172340A (en) * 2018-10-16 2019-01-11 泗水县人民医院 A kind of rhinitis fumigation treatment device
US20220152418A1 (en) * 2019-03-08 2022-05-19 Peach Tech Rhinitis treatment device
US11801396B1 (en) * 2020-03-10 2023-10-31 Cosmo Haralambidis Wearable device including UVC light source for reduction in virus and bacteria transmission
US11684798B2 (en) 2020-03-19 2023-06-27 Know Bio, Llc Illumination devices for inducing biological effects
US11752359B2 (en) 2020-03-19 2023-09-12 Know Bio, Llc Illumination devices for inducing biological effects
US11147984B2 (en) 2020-03-19 2021-10-19 Know Bio, Llc Illumination devices for inducing biological effects
US11654294B2 (en) 2021-03-15 2023-05-23 Know Bio, Llc Intranasal illumination devices

Also Published As

Publication number Publication date
CA2130308A1 (en) 1995-08-25
JPH07236700A (en) 1995-09-12
JP3635108B2 (en) 2005-04-06
EP0672435A1 (en) 1995-09-20
IL108772A0 (en) 1994-05-30

Similar Documents

Publication Publication Date Title
US5683436A (en) Treatment of rhinitis by biostimulative illumination
US5500009A (en) Method of treating herpes
US5549660A (en) Method of treating acne
KR200335313Y1 (en) Alopecia-healing comb using LASER and LED
US7101384B2 (en) Light processing of selected body components
US6187029B1 (en) Photo-thermal treatment device
KR100535159B1 (en) Improved Hand-held laser Device
US5591219A (en) Frequency modulator
US8439927B2 (en) Method of using a multi-probe laser device
US20080125835A1 (en) Method and apparatus for light therapy
US20090005631A1 (en) Photo-magnetic radiation device
US20050024853A1 (en) Modularized light processing of body components
WO1995010243A1 (en) Apparatus for treatment of the oral cavity
MX2012001515A (en) Handheld low-level laser therapy apparatus.
ES2228950T3 (en) ACUPUNCTURE DEVICE.
US7131989B2 (en) Apparatus and method for applying a sequence of therapeutic lights to specific points on a patient's body
KR20140147215A (en) A alopecia-healing device
US20040002744A1 (en) Frequency modulator
KR200405265Y1 (en) A light irradiation device for medical treatment using LED
KR20210133860A (en) Helmet for preventing hair loss by using the laser for medical treatment
JPH07100219A (en) Medical treatment of acne
KR20090003968U (en) Luminous Apparatus
US20180169434A1 (en) Treatment of Neurodegenerative Diseases Using Light Therapy
WO2001032262A1 (en) Miniature cluster laser therapy device
RU2523669C1 (en) Scanning laser therapeutic apparatus

Legal Events

Date Code Title Description
AS Assignment

Owner name: AMRON, LTD., ISRAEL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MENDES, EMANUEL;NEUMAN, ITAII;REEL/FRAME:007126/0714

Effective date: 19940602

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: SYRO LTD., ISRAEL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMRON, LTD.;REEL/FRAME:011027/0004

Effective date: 20000724

FEPP Fee payment procedure

Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS - SMALL BUSINESS (ORIGINAL EVENT CODE: SM02); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: SYRO TECHNOLOGIES, INC., DELAWARE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SYRO LTD.;REEL/FRAME:013516/0909

Effective date: 20021117

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
SULP Surcharge for late payment

Year of fee payment: 7

AS Assignment

Owner name: SYRO RESEARCH & DEVELOPMENT TECHNOLOGIES LTD., ISR

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SYRO TECHNOLOGIES, INC.;REEL/FRAME:017519/0382

Effective date: 20060425

REMI Maintenance fee reminder mailed
FPAY Fee payment

Year of fee payment: 12

SULP Surcharge for late payment

Year of fee payment: 11

AS Assignment

Owner name: MENDES, EMANUEL, ISRAEL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SYRO RESEARCH & DEVELOPMENT TECHNOLOGIES LTD.;REEL/FRAME:023510/0433

Effective date: 20091112